These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18047735)

  • 21. The cystic-fibrosis-associated ΔF508 mutation confers post-transcriptional destabilization on the C. elegans ABC transporter PGP-3.
    He L; Skirkanich J; Moronetti L; Lewis R; Lamitina T
    Dis Model Mech; 2012 Nov; 5(6):930-9. PubMed ID: 22569626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the ubiquitin proteasome system in Alzheimer's disease.
    Upadhya SC; Hegde AN
    BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S12. PubMed ID: 18047736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unmet needs in cystic fibrosis.
    Rubin BK
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):49-52. PubMed ID: 30063865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Approaches for Potential Therapy of Cystic Fibrosis.
    Sawczak V; Getsy P; Zaidi A; Sun F; Zaman K; Gaston B
    Curr Drug Targets; 2015; 16(9):923-36. PubMed ID: 25557257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biosynthesis of cystic fibrosis transmembrane conductance regulator.
    Pranke IM; Sermet-Gaudelus I
    Int J Biochem Cell Biol; 2014 Jul; 52():26-38. PubMed ID: 24685677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can correcting the ΔF508-CFTR proteostasis-defect rescue CF lung disease?
    Valle CW; Vij N
    Curr Mol Med; 2012 Aug; 12(7):860-71. PubMed ID: 22697346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CFTR and chaperones: processing and degradation.
    Amaral MD
    J Mol Neurosci; 2004; 23(1-2):41-8. PubMed ID: 15126691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon.
    Mall M; Kreda SM; Mengos A; Jensen TJ; Hirtz S; Seydewitz HH; Yankaskas J; Kunzelmann K; Riordan JR; Boucher RC
    Gastroenterology; 2004 Jan; 126(1):32-41. PubMed ID: 14699484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis.
    Grubb BR; Gabriel SE; Mengos A; Gentzsch M; Randell SH; Van Heeckeren AM; Knowles MR; Drumm ML; Riordan JR; Boucher RC
    Am J Respir Cell Mol Biol; 2006 Mar; 34(3):355-63. PubMed ID: 16284361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Divergent signaling via SUMO modification: potential for CFTR modulation.
    Ahner A; Gong X; Frizzell RA
    Am J Physiol Cell Physiol; 2016 Feb; 310(3):C175-80. PubMed ID: 26582473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanistic Approaches to Improve Correction of the Most Common Disease-Causing Mutation in Cystic Fibrosis.
    Bali V; Lazrak A; Guroji P; Matalon S; Bebok Z
    PLoS One; 2016; 11(5):e0155882. PubMed ID: 27214033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-linking of ΔF508-CFTR promotes its trafficking to the plasma membrane.
    Bernard K; Kirk KL
    Channels (Austin); 2010; 4(4):251-4. PubMed ID: 20581470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules.
    Van Goor F; Straley KS; Cao D; González J; Hadida S; Hazlewood A; Joubran J; Knapp T; Makings LR; Miller M; Neuberger T; Olson E; Panchenko V; Rader J; Singh A; Stack JH; Tung R; Grootenhuis PD; Negulescu P
    Am J Physiol Lung Cell Mol Physiol; 2006 Jun; 290(6):L1117-30. PubMed ID: 16443646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    Chung WJ; Goeckeler-Fried JL; Havasi V; Chiang A; Rowe SM; Plyler ZE; Hong JS; Mazur M; Piazza GA; Keeton AB; White EL; Rasmussen L; Weissman AM; Denny RA; Brodsky JL; Sorscher EJ
    PLoS One; 2016; 11(10):e0163615. PubMed ID: 27732613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
    Kuk K; Taylor-Cousar JL
    Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis. A novel class of mutation.
    Haardt M; Benharouga M; Lechardeur D; Kartner N; Lukacs GL
    J Biol Chem; 1999 Jul; 274(31):21873-7. PubMed ID: 10419506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of calnexin in the ER quality control and productive folding of CFTR; differential effect of calnexin knockout on wild-type and DeltaF508 CFTR.
    Okiyoneda T; Niibori A; Harada K; Kohno T; Michalak M; Duszyk M; Wada I; Ikawa M; Shuto T; Suico MA; Kai H
    Biochim Biophys Acta; 2008 Sep; 1783(9):1585-94. PubMed ID: 18457676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annexin A5 increases the cell surface expression and the chloride channel function of the DeltaF508-cystic fibrosis transmembrane regulator.
    Le Drévo MA; Benz N; Kerbiriou M; Giroux-Metges MA; Pennec JP; Trouvé P; Férec C
    Biochim Biophys Acta; 2008 Oct; 1782(10):605-14. PubMed ID: 18773956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.
    Persu A; Devuyst O; Lannoy N; Materne R; Brosnahan G; Gabow PA; Pirson Y; Verellen-Dumoulin C
    J Am Soc Nephrol; 2000 Dec; 11(12):2285-2296. PubMed ID: 11095651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.